UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.01B |
| 2 |
Microsoft
MSFT
|
+$922M |
| 3 |
Amazon
AMZN
|
+$646M |
| 4 |
Tesla
TSLA
|
+$554M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$496M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$1.04B |
| 2 |
Linde
LIN
|
+$949M |
| 3 |
ExxonMobil
XOM
|
+$313M |
| 4 |
VMW
VMware, Inc
VMW
|
+$217M |
| 5 |
NVIDIA
NVDA
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 13.37% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Financials | 10.99% |
| 5 | Communication Services | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Edgewell Personal Care
EPC
$1.25B
| $2.38M | ﹤0.01% |
64,295
-8,928
| -12% | -$345K |
|
1477
Krystal Biotech
KRYS
$10.1B
| $2.37M | ﹤0.01% |
20,426
+3,633
| +22% | +$443K |
|
1478
Viavi Solutions
VIAV
$9.12B
| $2.37M | ﹤0.01% |
259,186
-18,262
| -7% | -$190K |
|
|
PRFT
1479
DELISTED
Perficient Inc
PRFT
| $2.37M | ﹤0.01% |
40,897
+1,498
| +4% | +$103K |
|
1480
Sotera Health
SHC
$5.09B
| $2.36M | ﹤0.01% |
157,368
+8,853
| +6% | +$149K |
|
|
AKRO
1481
DELISTED
Akero Therapeutics
AKRO
| $2.35M | ﹤0.01% |
46,539
+8,449
| +22% | +$393K |
|
1482
Omnicell
OMCL
$1.61B
| $2.35M | ﹤0.01% |
52,262
+2,684
| +5% | +$163K |
|
1483
Xenon Pharmaceuticals
XENE
$6.06B
| $2.35M | ﹤0.01% |
68,801
+15,749
| +30% | +$589K |
|
1484
Bankunited
BKU
$3.37B
| $2.34M | ﹤0.01% |
102,965
+2,500
| +2% | +$64.1K |
|
1485
Alpha Metallurgical Resources
AMR
$1.74B
| $2.34M | ﹤0.01% |
8,995
-731
| -8% | -$143K |
|
1486
Certara
CERT
$1.26B
| $2.33M | ﹤0.01% |
160,524
+29,982
| +23% | +$504K |
|
1487
Independent Bank
INDB
$3.99B
| $2.33M | ﹤0.01% |
47,475
+1,753
| +4% | +$93.3K |
|
1488
Greif
GEF
$4.92B
| $2.32M | ﹤0.01% |
34,747
-5,942
| -15% | -$421K |
|
1489
Tidewater
TDW
$3.73B
| $2.32M | ﹤0.01% |
32,610
-2,567
| -7% | -$162K |
|
|
ODP
1490
DELISTED
ODP
ODP
| $2.31M | ﹤0.01% |
50,127
-11,253
| -18% | -$541K |
|
1491
Madrigal Pharmaceuticals
MDGL
$10.8B
| $2.31M | ﹤0.01% |
15,826
+354
| +2% | +$66.6K |
|
1492
Q2 Holdings
QTWO
$3.8B
| $2.3M | ﹤0.01% |
71,280
+20,482
| +40% | +$678K |
|
1493
Eastern Bankshares
EBC
$5.26B
| $2.3M | ﹤0.01% |
183,167
+12,380
| +7% | +$167K |
|
1494
Ingevity
NGVT
$2.51B
| $2.3M | ﹤0.01% |
48,242
+4,534
| +10% | +$247K |
|
1495
Enerpac Tool Group
EPAC
$1.83B
| $2.3M | ﹤0.01% |
86,846
-3,734
| -4% | -$99.7K |
|
1496
IonQ
IONQ
$13.6B
| $2.29M | ﹤0.01% |
154,129
+93,548
| +154% | +$1.47M |
|
1497
Reynolds Consumer Products
REYN
$5.26B
| $2.29M | ﹤0.01% |
89,445
+9,168
| +11% | +$250K |
|
1498
Delek US
DK
$4.16B
| $2.28M | ﹤0.01% |
80,217
-4,443
| -5% | -$120K |
|
1499
First Financial Bancorp
FFBC
$3.55B
| $2.27M | ﹤0.01% |
116,037
-13,555
| -10% | -$290K |
|
1500
StoneX
SNEX
$9.26B
| $2.27M | ﹤0.01% |
118,711
| – | – |
|
Similar funds
UBS AM's Q3 2023 Portfolio in Review
As of Q3 2023, UBS AM held 2,762 positions worth $223B, up 8.1% from $206B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
UBS AM deployed $7.28B of net new capital in Q3 2023, opening 89 new positions and adding to 1,400 existing holdings. Its largest new stake was Kenvue: 8,680,819 shares worth $174M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Abbott, an estimated $1.04B trimmed.
- UBS AM's largest Q3 2023 buy was Kenvue: 8,680,819 shares worth $174M.
- UBS AM added most to Apple in Q3 2023, an estimated $1.01B increase.
- UBS AM's biggest Q3 2023 reduction was Abbott, cutting an estimated $1.04B.
- UBS AM fully exited World Wrestling Entertainment in Q3 2023, selling an estimated $128M.
- UBS AM's ten largest holdings make up 26% of its $223B portfolio in Q3 2023.
- UBS AM opened 89 new positions and closed 174 in Q3 2023.
- UBS AM's portfolio value rose 8.1% quarter-over-quarter to $223B.
Based on UBS AM's 13F filing for Q3 2023, filed 13 Nov 2023.